CMCSA β€” COMCAST CORP NEW

Ownership history in Trilogy Capital Inc.  Β·  9 quarters on record

This page tracks every 13F SEC filing in which Trilogy Capital Inc. reported a position in COMCAST CORP NEW (CMCSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.15% (2025 Q1)
πŸ“Š Avg. % of fund
0.1%
πŸ“… First filed
2018 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
9

Position Intelligence

Trilogy Capital Inc. Γ— CMCSA AI Analytics

πŸ“‰ Trilogy Capital Inc. underperformed the S&P 500 by –67.1% annually on this CMCSA position. Timing score: 43% (3/7 decisions correct). Average cost basis: $34.23. Maximum drawdown during holding period: –22.2%.

πŸ“ˆ Position Alpha vs SPY
-67.1%
annualised excess return

❌ Significantly underperformed the S&P 500 by 67.1% ann.
7 quarters analyzed

⏱️ Timing Score
43%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
3 of 7 add/trim decisions correct

πŸ’° Entry Quality
$34.23
-15.9% vs current ($28.80)

Best entry: $25.05 (2018 Q2)  Β·  Worst: $37.01 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–22.2%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
89%
buy-side decisions

8 adds Β· 1 trim. Bought during 3 of 4 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.12% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    CMCSA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 80,327 -1,627 -2.0% 0.12% $2.5M $28.80
2025 Q2 ADDED 81,954 +2,846 +3.6% 0.14% $2.9M $32.42
2025 Q1 ADDED 79,108 +7,559 +10.6% 0.15% $2.9M $33.21
2024 Q4 ADDED 71,549 +3,187 +4.7% 0.14% $2.7M $33.50
2024 Q3 ADDED 68,362 +1,121 +1.7% 0.14% $2.9M $37.01
2024 Q2 ADDED 67,241 +65,485 +3729.2% 0.14% $2.6M $34.41
2018 Q3 ADDED 1,756 +1 +0.1% 0.01% $62K $27.19
2018 Q2 ADDED 1,755 +1 +0.1% 0.01% $58K $25.05
2018 Q1 INITIATED 1,754 β€” β€” 0.01% $60K β€”

🏒 Other funds also holding CMCSA

As of 2025 Q4 β€” sorted by position size

Silver Rock Financial LP 3Y 7Y 32.69% Long Focus Capital Management, LLC 3Y 18.4% GOLDENTREE ASSET MANAGEMENT LP 3Y 7Y 12.66% Metropolis Capital Ltd 3Y 7Y 7.65% Kiltearn Partners LLP 3Y 7Y 6.27% Hall Kathryn A. 3Y 7Y 5.83% Compass Rose Asset Management, LP 5.7% Wilmington Savings Fund Society, FSB 3Y 7Y 5.61% Harbor Island Capital LLC 3Y 7Y 5.51% Aryeh Capital Management Ltd. 3Y 5.46%
← Back to Trilogy Capital Inc. Holdings